1. August 22
Company Confidential / EVA Pharma-
August 22
Company Confidential / EVA Pharma-
1
Company Confidential/ EVA Pharma/ XXX Slides
Salmetocort & Inhalex
Flexible Combination for Asthma &
COPD
EGYPT, June 2022
2. August 22
Company Confidential / EVA Pharma-
August 22
Company Confidential / EVA Pharma-
2
Company Confidential/ EVA Pharma/ XXX Slides
3. August 22
Company Confidential / EVA Pharma-
August 22
Company Confidential / EVA Pharma-
3
Company Confidential/ EVA Pharma/ XXX Slides
4. August 22
Company Confidential / EVA Pharma-
August 22
Company Confidential / EVA Pharma-
4
Company Confidential/ EVA Pharma/ XXX Slides
Delivered dose at different inspiratory flow rates
180
200
220
240
90 L/min 60 L/min 30 L/min
Fluticasone Delivered dose
at different inspiratory flow rates
Seritide Salmetocort
Delivered
dose
in
mcg
Inspiratory flow rate
5. August 22
Company Confidential / EVA Pharma-
August 22
Company Confidential / EVA Pharma-
5
Company Confidential/ EVA Pharma/ XXX Slides
6. August 22
Company Confidential / EVA Pharma-
August 22
Company Confidential / EVA Pharma-
6
Company Confidential/ EVA Pharma/ XXX Slides
Its very important to recommend
easy to use inhaler as
Incorrect inhaler technique leads to
hospitalization , ER visits & Oral CS use
7. August 22
Company Confidential / EVA Pharma-
August 22
Company Confidential / EVA Pharma-
7
Company Confidential/ EVA Pharma/ XXX Slides
8. August 22
Company Confidential / EVA Pharma-
August 22
Company Confidential / EVA Pharma-
8
Company Confidential/ EVA Pharma/ XXX Slides
9. August 22
Company Confidential / EVA Pharma-
August 22
Company Confidential / EVA Pharma-
9
Company Confidential/ EVA Pharma/ XXX Slides
SALMETOCORT 250/50 1 inh twice daily
results in significantly greater symptom free
days (73.8%) , less annual mean exacerbation
rate (47%) & less exposure to oral CS (46%) vs
AMD of BUD/FOR 200/6 up to max. dose 4 inh
twice daily
13. 13
INHALEX assure full efficacy 24/7 while Gly efficacy reduced to 1/3
after 16 hrs
So INHALEX help COPD patients perform their daily activities
normally & enjoy better QoL
19. August 22
Company Confidential / EVA Pharma-
August 22
Company Confidential / EVA Pharma-
19
Company Confidential/ EVA Pharma/ XXX Slides
GOLD Guidelines 2022
21. 21
Treatment with INHALEX plus Salmetocort 250/50 is an effective
combination for severe COPD patients with greater improvement in
patients’ QoL than SFC alone
22. August 22
Company Confidential / EVA Pharma-
August 22
Company Confidential / EVA Pharma-
33
Company Confidential/ EVA Pharma/ XXX Slides
23. August 22
Company Confidential / EVA Pharma-
August 22
Company Confidential / EVA Pharma-
34
Company Confidential/ EVA Pharma/ XXX Slides
CDMhaler – Compact Dual Motion Mechanism